Colapietra, F.; Della Monica, P.; Di Napoli, R.; França Vieira e Silva, F.; Settembre, G.; Marino, M.M.; Ballini, A.; Cantore, S.; Di Domenico, M.
Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine Tumors. J. Clin. Med. 2025, 14, 2622.
https://doi.org/10.3390/jcm14082622
AMA Style
Colapietra F, Della Monica P, Di Napoli R, França Vieira e Silva F, Settembre G, Marino MM, Ballini A, Cantore S, Di Domenico M.
Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine Tumors. Journal of Clinical Medicine. 2025; 14(8):2622.
https://doi.org/10.3390/jcm14082622
Chicago/Turabian Style
Colapietra, Federica, Paola Della Monica, Raffaella Di Napoli, Fábio França Vieira e Silva, Giuliana Settembre, Maria Michela Marino, Andrea Ballini, Stefania Cantore, and Marina Di Domenico.
2025. "Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine Tumors" Journal of Clinical Medicine 14, no. 8: 2622.
https://doi.org/10.3390/jcm14082622
APA Style
Colapietra, F., Della Monica, P., Di Napoli, R., França Vieira e Silva, F., Settembre, G., Marino, M. M., Ballini, A., Cantore, S., & Di Domenico, M.
(2025). Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine Tumors. Journal of Clinical Medicine, 14(8), 2622.
https://doi.org/10.3390/jcm14082622
